Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
-
Cantor Fitzgerald Reiterates a 'Buy' on Salix Pharmaceuticals (SLXP); Is Relistor Still in Play?
-
Cantor Fitzgerald Upgrades Salix Pharmaceuticals (SLXP) to Buy
-
Cantor Fitzgerald Downgrades Salix Pharmaceuticals (SLXP) to Hold; Relistor Receives Complete Response Letter
-
Cantor Fitzgerald Maintains a 'Buy' on Salix Pharmaceuticals (SLXP); Suggests Buying Into Weakness
-
Cantor Fitzgerald Maintains a 'Buy' on Salix Pharmaceuticals (SLXP); Relistor News Provides Upside To Our Estimates
-
Cantor Fitzgerald Starts Salix Pharmaceuticals (SLXP) at Buy; Core Business Undervalued; Pipeline Risk Remains
